ISRCTN26689999已完成不适用
A multicentre, randomised trial of primary chemotherapy in inoperable cervical cancer
Cancer Research UK (CRUK) (UK)0 个研究点目标入组 172 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 172
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Histologically proven invasive squamous cell carcinoma of the cervix uteri
- •2. Inoperable disease, that is stage II, III or IVA. Stage IIA disease may be included if deemed inoperable by the referring gynaecologist
- •3. No previous treatment for invasive cervical cancer
- •4. World Health Organisation (WHO) performance status >2
- •5. Adequate renal hepatic and haematological function
- •6. Adequate pulmonary function
- •7. Patients with a probability of <0.2 of not developing severe encephalopathy with ifosfamide/mensa treatment are excluded
- •8. Expected survival of >3 months
- •9. No second primary tumour other than basal cell carcinoma of the skin
- •10. No other serious medical or psychological condition precluding treatment
排除标准
- •Not provided at time of registration
研究者
相似试验
招募中
3 期
Primary endoscopic hemostasis after EST between balloon tamponade technique and self-assembling peptidePerformance status 0 to 3Bleeding, Endoscopic sphincterotomy, Endoscopic retrograde cholangiopancreatography, PuraStatD006470JPRN-jRCTs052230103Ogura Takeshi130
进行中（未招募）
1 期
FLIGHT - A multicentre randomised trial of first line treatment pathways for newly diagnosied immune thrombocytopenia patients.Immune ThrombocytopeniaEUCTR2017-001171-23-GBniversity Hospitals Bristol NHS Foundation Trust120
进行中（未招募）
不适用
A multi-centre randomised trial of therapeutic intervention at primary HIV-1 infection - SPARTACHIV infectionMedDRA version: 8Level: LLTClassification code 10020161EUCTR2004-000446-20-IEImperial College360
已完成
不适用
Xience® or Vision® stent - Management of Angina in the elderlyCoronary diseaseacute coronary syndromesCirculatory SystemOther acute ischaemic heart diseasesISRCTN92243650Brighton and Sussex University Hospitals NHS Trust (UK)800
进行中（未招募）
1 期
A trial to compare standard of care (SOC) alone with SOC plus hydroxychloroquine or SOC with a combination of hydroxycholorquine and azithromysin in the treatment of coronovirusSARS-CoV-2 PCR-positive populationMedDRA version: 20.0Level: PTClassification code 10070255Term: Coronavirus test positiveSystem Organ Class: 10022891 - InvestigationsEUCTR2020-001265-36-IEniversity College Dublin267